|
||
§




* Department of Cell Biology, Parathyroid hormone-related peptide
(PTHrP) appears to play a major role in skeletal development. Targeted disruption of the PTHrP gene in
mice causes skeletal dysplasia with accelerated chondrocyte maturation (Amizuka, N., H. Warshawsky, J.E.
Henderson, D. Goltzman, and A.C. Karaplis. 1994. J. Cell Biol. 126:1611-1623; Karaplis, A.C., A. Luz, J. Glowacki, R.T. Bronson, V.L.J. Tybulewicz, H.M.
Kronenberg, and R.C. Mulligan. 1994. Genes Dev. 8:
277-289). A constitutively active mutant PTH/PTHrP
receptor has been found in Jansen-type human metaphyseal chondrodysplasia, a disease characterized by
delayed skeletal maturation (Schipani, E., K. Kruse,
and H. Jüppner. 1995. Science (Wash. DC). 268:98-
100). The molecular mechanisms by which PTHrP affects this developmental program remain, however,
poorly understood. We report here that PTHrP increases the expression of Bcl-2, a protein that controls
programmed cell death in several cell types, in growth
plate chondrocytes both in vitro and in vivo, leading to
delays in their maturation towards hypertrophy and
apoptotic cell death. Consequently, overexpression of
PTHrP under the control of the collagen II promoter in
transgenic mice resulted in marked delays in skeletal
development. As anticipated from these results, deletion of the gene encoding Bcl-2 leads to accelerated
maturation of chondrocytes and shortening of long bones. Thus, Bcl-2 lies downstream of PTHrP in a pathway that controls chondrocyte maturation and skeletal
development.
Department of Orthopaedics, ¶ Department of Internal Medicine, ** Department of Cellular and
Molecular Physiology, Yale University School of Medicine, New Haven, Connecticut, 06510; § Department of Bone Pathology,
Hamburg University School of Medicine, 20246 Hamburg, Germany; and
Tokyo Metropolitan Institute of Medical Science,
Tokyo 113, Japan
This article has been cited by other articles:
|
|